What is Positive Development?
Positive Development operates at the intersection of behavioral health and innovative clinical care. By utilizing a developmental model that prioritizes the individuality of each child, the company moves beyond traditional, rigid therapeutic frameworks. This approach emphasizes the child's unique processing capabilities and inherent strengths, fostering a more holistic environment for growth. As a leader in the autism therapy space, the organization is effectively bridging the gap between clinical necessity and personalized, empathetic care, establishing a robust market position that attracts significant institutional backing from top-tier healthcare and technology investors.
How much funding has Positive Development raised?
Positive Development has raised a total of $136.7M across 4 funding rounds:
Seed
$2.9M
Series A
$37.3M
Series C
$51.5M
Debt
$45M
Seed (2020): $2.9M with participation from Operator Partners
Series A (2022): $37.3M, investors not publicly disclosed
Series C (2025): $51.5M supported by Digitalis Ventures, Flare Capital Partners, B Capital Group, Healthworx, and aMoon
Debt (2026): $45M featuring Silicon Valley Bank and Pinegrove
Key Investors in Positive Development
Digitalis Ventures
Digitalis Ventures engineers solutions to unmet needs in health by leveraging deep technical, financial, and domain expertise, focusing on scaling enduring enterprises in the biotechnology and technology-enabled health sectors.
Flare Capital Partners
Flare Capital Partners is a leading investor focused on healthcare technology, collaborating with entrepreneurs to enhance healthcare outcomes and reduce costs through a strategic network of industry partners.
B Capital Group
B Capital is a global venture capital firm that focuses on empowering entrepreneurs by investing in early and late-stage companies within the Technology, Healthcare, and Climate sectors.
What's next for Positive Development?
With this latest capital injection, Positive Development is well-positioned to accelerate its operational footprint and enhance its service delivery infrastructure. The strategic focus will likely shift toward expanding its clinical network and integrating advanced data-driven insights to refine its developmental therapy protocols. By leveraging the expertise of its diverse investor base—which includes specialists in healthcare technology and venture debt—the company is prepared to navigate the complexities of scaling high-touch clinical services. Future initiatives will likely prioritize the digitization of patient outcomes and the optimization of care delivery models to ensure long-term sustainability and impact in the competitive behavioral health landscape.
See full Positive Development company page
